The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.

Source:http://linkedlifedata.com/resource/pubmed/id/18283239

Download in:

View as

General Info

PMID
18283239